Process analytical technology (PAT): applications to flow processes for active pharmaceutical ingredient (API) development

被引:19
|
作者
Talicska, Courtney N. [1 ]
O'Connell, Eamon C. [1 ]
Ward, Howard W. [1 ]
Diaz, Angel R. [1 ]
Hardink, Mark A. [1 ]
Foley, David A. [1 ,2 ,3 ]
Connolly, Douglas [4 ]
Girard, Kevin P. [1 ]
Ljubicic, Tomislav [1 ]
机构
[1] Pfizer Worldwide Res & Dev, Analyt Res & Dev, 445 Eastern Point Rd, Groton, CT 06340 USA
[2] Pfizer, New York, NY USA
[3] Merck Res & Dev, 90 E Scott Ave, Rahway, NJ 07065 USA
[4] Eurofins Sci Pfizer Worldwide Res & Dev, 445 Eastern Point Rd, Groton, CT 06340 USA
关键词
CRYSTALLIZATION PROCESS; CHEMISTRY; PERSPECTIVES; REACTOR;
D O I
10.1039/d2re00004k
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
As flow processes are being increasingly utilized for development of active pharmaceutical ingredients (APIs), the importance of process analytical technology (PAT) in the pharmaceutical industry is growing. Here, we describe a variety of PAT tools (FTIR, on-line UPLC-MS, flow NMR) used in support of flow chemistry platforms at Pfizer as part of the Flexible API Supply Technology (FAST) initiative. A blend of qualitative and quantitative PAT approaches are described, with each method tailored to the specific aims of each individual platform. PAT is demonstrated to be beneficial for real-time process understanding and for rapid optimization of chemical reactions in the flow-chemistry space, reducing the need for off-line analytics and helping to accelerate development timelines.
引用
收藏
页码:1419 / 1428
页数:10
相关论文
共 50 条
  • [21] Process Analytical Technology for Crystallization of Active Pharmaceutical Ingredients
    Malwade, Chandrakant R.
    Qu, Haiyan
    CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (21) : 2456 - 2472
  • [22] Acoustic-resonance spectrometry as a process analytical technology for the quantification of active pharmaceutical ingredient in semi-solids
    Medendorp, Joseph
    Buice, Robert G., Jr.
    Lodder, Robert A.
    AAPS PHARMSCITECH, 2006, 7 (03):
  • [23] Acoustic-resonance spectrometry as a process analytical technology for the quantification of active pharmaceutical ingredient in semi-solids
    Joseph Medendorp
    Robert G. Buice
    Robert A. Lodder
    AAPS PharmSciTech, 7 (3)
  • [24] Understanding and preventing polymer formation in an active pharmaceutical ingredient (API).
    Moser, BA
    Hanquier, JM
    Baker, JC
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U251 - U251
  • [25] Stable isotopic composition of the active pharmaceutical ingredient (API) naproxen
    Wokovich, AM
    Spencer, JA
    Westenberger, BJ
    Buhse, LF
    Jasper, JP
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2005, 38 (04) : 781 - 784
  • [26] Trends in Process Analytical Technology PAT
    Maiwald, Michael
    Daum, Werner
    TM-TECHNISCHES MESSEN, 2011, 78 (12) : 547 - 548
  • [27] Process analytical technology (PAT) for biopharmaceuticals
    Glassey, Jarka
    Gernaey, Krist V.
    Clemens, Christoph
    Schulz, Torsten W.
    Oliveira, Rui
    Striedner, Gerald
    Mandenius, Carl-Fredrik
    BIOTECHNOLOGY JOURNAL, 2011, 6 (04) : 369 - 377
  • [28] Process analytical technology (PAT) for bioprocessing
    Williams, Abasha
    Chavez, Brittany
    Agarabi, Cyrus
    Brorson, Kurt
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [29] Process Analytical Technology: tools and applications in pharmaceutical manufacturing
    Wiss, Jacques
    CHIMICA OGGI-CHEMISTRY TODAY, 2015, 33 (02) : 30 - 33
  • [30] Process Analytical Technology (PAT) and Quality by Design (QbD) in the regulatory environment of the pharmaceutical industry
    Schmidt-Bader T.
    Chemie-Ingenieur-Technik, 2010, 82 (04) : 415 - 428